Dr. Sunil Saldanha

Dr. Sunil Saldanha
Born	India
Nationality	Indian
Profession	Medical professional, Healthcare innovator
Education	MBBS, MBA in Biomedical/Medical Engineering
Alma Mater	Saint Catharine College; St. John's University
Notable Works	Cryobank at EmProcell (SlideShare presentation)
Known For	Clinical diagnostics, Stem cell therapies, Artificial intelligence in healthcare, Bioresonance therapy
Years Active	1990–present
Website	sunilsaldanha at BrandYourself

Dr. Sunil Saldanha is an Indian medical professional, researcher, and healthcare innovator with more than 25 years of experience in diagnostics, clinical research, stem cell therapy, and the application of artificial intelligence in medicine. He is regarded for combining holistic and technology-driven approaches to patient care, and for advancing the use of bioresonance therapy and regenerative medicine in India and abroad.

Early life and education

Saldanha earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from Saint Catharine College in 1989. Seeking to combine medical practice with innovation and management, he later pursued a Master of Business Administration (MBA) in Biomedical/Medical Engineering at St. John’s University between 1991 and 1995. His academic training laid the foundation for his career in healthcare management, diagnostics, and clinical innovation.

Career

Thyrocare Technologies Limited

Saldanha spent nearly a decade with Thyrocare Technologies Limited, one of India’s leading diagnostic chains. During his tenure, he contributed extensively to thyroid diagnostics, laboratory medicine, and healthcare operations. His work included enhancing service quality and medical management systems that supported the company’s expansion in preventive and diagnostic healthcare services.

EmProcell Clinical Research

For over eleven years, Saldanha was associated with EmProcell Clinical Research, where he directed his focus toward regenerative medicine and stem cell therapies. At EmProcell he explored the therapeutic applications of fetal stem cells for conditions such as chronic wounds, ischemia, and ulcers. He also helped establish ethical standards for clinical trials involving regenerative medicine and contributed to developing protocols for fetal stem cell therapy. His SlideShare presentation “Cryobank at EmProcell” provides details of his work with cryopreservation of hematopoietic, neural, angioblast, and neuroblast stem cells.

BMS AI Healthcare R&D Ltd

Saldanha currently serves as a leading figure at BMS AI Healthcare R&D Ltd., a company focused on integrating artificial intelligence into diagnostics and treatment planning. His work involves building AI-powered healthcare systems designed to improve decision-making, reduce errors in diagnostics, and personalize treatment plans. This phase of his career reflects his vision of combining traditional medicine with cutting-edge technologies.

Work in bioresonance

In addition to clinical and AI-based approaches, Saldanha has been a practitioner and researcher of bioresonance therapy. Bioresonance is a non-invasive technique that utilizes electromagnetic frequencies to detect and treat conditions. Although considered complementary and alternative in nature, Saldanha promotes bioresonance as part of a holistic healthcare model, aiming to provide individualized, non-toxic treatment options for patients. He has advocated for the role of bioresonance in managing chronic illnesses, allergies, and energy-related imbalances.

Research contributions

Throughout his career, Saldanha has authored and presented several case studies and research papers on regenerative medicine and clinical innovations. His work in fetal stem cell therapy focused on hematopoietic stem cells for blood-related disorders, neural stem cells for neurological repair, and angioblasts for vascular regeneration. His studies emphasized both the scientific potential and ethical considerations of stem cell-based treatments. Saldanha’s research has been shared through platforms such as SlideShare and in professional conferences, where he has highlighted the importance of cryobanking and clinical trial frameworks for stem cell innovation. His ability to bridge clinical practice, laboratory research, and healthcare management has been noted as a distinctive aspect of his contributions.

Notable projects

Some of the prominent initiatives and projects associated with Saldanha include:

• CREAME Anti-Ageing Therapy: A program focused on regenerative approaches to delay cellular ageing and improve vitality.

• Chronic Limb Ischemia Treatment: Application of fetal stem cell therapy and bioresonance modalities to improve circulation in ischemic limbs.

• AI-powered diagnostic systems: Development of machine learning and AI frameworks for predictive diagnostics and precision treatment.

• Fetal stem cell therapy research: Pioneering investigations into the clinical utility of fetal hematopoietic and neural cells.

Skills and expertise

Saldanha’s expertise spans several intersecting domains of modern medicine and biomedical innovation:

• Clinical diagnostics and laboratory management

• Stem cell therapy and regenerative medicine

• Artificial intelligence in healthcare systems

• Bioresonance and holistic medicine

• Biomedical innovation and product development

• Business development and healthcare management

Legacy and impact

Over more than two decades, Saldanha has become a notable advocate for the integration of conventional diagnostics, advanced regenerative therapies, and emerging digital technologies in healthcare. His leadership roles across diagnostic companies, clinical research organizations, and AI healthcare start-ups position him as a pioneer in multidisciplinary medical innovation. By promoting holistic therapies alongside artificial intelligence-driven solutions, Saldanha exemplifies a future-oriented model of medicine that bridges traditional clinical practice with biomedical technology.

External links

• BrandYourself – Sunil Saldanha (brandyourself.com)

• LinkedIn – Dr. Sunil Saldanha (linkedin.com)

• SlideShare – Sunil Saldanha (slideshare.net)